Stock Taper 
ORBIMED ADVISORS LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Trevi Therapeutics, Inc. | TRVI | 1.43M | $26.67M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 1.07M | $15.29M |
 Crinetics Pharmaceuticals, Inc. | CRNX | 999K | $37.38M |
 CG Oncology Inc. | CGON | 972.8K | $69.12M |
 LifeStance Health Group, Inc. | LFST | 947.4K | $10.15M |
 Bristol-Myers Squibb Company | BMY | 925K | $53.3M |
 AstraZeneca PLC | AZN | 915.7K | $171.08M |
 Xenon Pharmaceuticals Inc. | XENE | 892.47K | $53.87M |
 Edwards Lifesciences Corporation | EW | 834.9K | $75.53M |
 Atai Beckley Inc. | ATAI | 797.5K | $4.2M |
 BioAge Labs Inc. | BIOA | 752.15K | $18.44M |
 Merck & Co., Inc. | MRK | 663.4K | $85.25M |
 Guardant Health, Inc. | GH | 583.7K | $87.57M |
 Alumis Inc. | ALMS | 548.16K | $15.43M |
 Abivax S.A. | ABVX | 546.52K | $72.83M |
 Janux Therapeutics, Inc. | JANX | 524.7K | $8.06M |
 Erasca, Inc. | ERAS | 495.9K | $9.08M |
 Nektar Therapeutics | NKTR | 465.35K | $32.49M |
 Aclaris Therapeutics, Inc. | ACRS | 421.5K | $2.23M |
 Kiniksa Pharmaceuticals International, plc | KNSA | 420.6K | $26.9M |